These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17376742

  • 1. Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.
    Gasová Z, Spísek R, Dolezalová L, Marinov I, Vítek A.
    Transfus Apher Sci; 2007 Apr; 36(2):149-58. PubMed ID: 17376742
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
    Rao V, Saunes M, Jørstad S, Moen T.
    Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
    [Abstract] [Full Text] [Related]

  • 3. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J.
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [Abstract] [Full Text] [Related]

  • 4. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R, British Photodermatology Group, UK Skin Lymphoma Group.
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [Abstract] [Full Text] [Related]

  • 5. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL, Dunbar NM, Meehan KR, Szczepiorkowski ZM, Lansigan F.
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [Abstract] [Full Text] [Related]

  • 6. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.
    Transplantation; 2007 Jul 15; 84(1):31-9. PubMed ID: 17627234
    [Abstract] [Full Text] [Related]

  • 7. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.
    Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, Locatelli F, Argiolu F, Miniero R, Zacchello G.
    Bone Marrow Transplant; 1996 Nov 15; 18 Suppl 2():175-81. PubMed ID: 8932825
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J, Taylor P, Russell-Jones R.
    Bone Marrow Transplant; 1999 May 15; 23(9):881-7. PubMed ID: 10338042
    [Abstract] [Full Text] [Related]

  • 9. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, Rowley SD.
    J Clin Apher; 2006 Oct 15; 21(3):181-7. PubMed ID: 16607632
    [Abstract] [Full Text] [Related]

  • 10. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
    Rao V, Ryggen K, Aarhaug M, Dai HY, Jørstad S, Moen T.
    J Eur Acad Dermatol Venereol; 2006 Oct 15; 20(9):1100-7. PubMed ID: 16987266
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J, Taylor P.
    Ther Apher Dial; 2008 Aug 15; 12(4):311-8. PubMed ID: 18789119
    [Abstract] [Full Text] [Related]

  • 12. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses.
    Garban F, Drillat P, Makowski C, Jacob MC, Richard MJ, Favrot M, Sotto JJ, Bensa JC, Cahn JY.
    Haematologica; 2005 Aug 15; 90(8):1096-101. PubMed ID: 16079109
    [Abstract] [Full Text] [Related]

  • 13. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ, Mitchell TJ, Whittaker SJ, Scarisbrick JJ, Seed PT, Russell-Jones R.
    Clin Exp Dermatol; 2004 May 15; 29(3):231-6. PubMed ID: 15115499
    [Abstract] [Full Text] [Related]

  • 14. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT, Ibatici A, Lamparelli T, Bruno B, Raiola AM, Dominietto A, Di Grazia C, Bregante S, Zia S, Ferrari GM, Stura P, Pogliani E, Bacigalupo A.
    Bone Marrow Transplant; 2008 Nov 15; 42(9):609-17. PubMed ID: 18660840
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J, Taylor P.
    J Clin Apher; 2002 Nov 15; 17(4):177-82. PubMed ID: 12494410
    [Abstract] [Full Text] [Related]

  • 16. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O, Arat M, Arslan O, Ayyildiz E, Sanli H, Beksac M, Ozcan M, Gürman G, Akan H.
    Transfus Apher Sci; 2004 Jun 15; 30(3):185-7. PubMed ID: 15172621
    [Abstract] [Full Text] [Related]

  • 17. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
    Quaglino P, Comessatti A, Ponti R, Peroni A, Mola F, Fierro MT, Savoia P, Novelli M, Bernengo MG.
    Int J Immunopathol Pharmacol; 2009 Jun 15; 22(2):353-62. PubMed ID: 19505389
    [Abstract] [Full Text] [Related]

  • 18. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment.
    Kanold J, Messina C, Halle P, Locatelli F, Lanino E, Cesaro S, Deméocq F, Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant; 2005 Mar 15; 35 Suppl 1():S69-71. PubMed ID: 15812535
    [Abstract] [Full Text] [Related]

  • 19. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S, Photopheresis Expert Group.
    Br J Dermatol; 2008 Apr 15; 158(4):659-78. PubMed ID: 18241274
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M, Di Renzo M, Rubegni P.
    Br J Dermatol; 2004 Jun 15; 150(6):1055-60. PubMed ID: 15214889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.